University of Dundee

Latest News

November 2020

  • Barley
    26 Nov 2020

    An international research team including scientists from the James Hutton Institute and the University of Dundee has reached a milestone on the way to unravelling the species-wide genetic diversity of domesticated barley.

  • University of Dundee logo on the Tower Building
    18 Nov 2020

    The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings.

  • 18 Nov 2020

    Six University of Dundee researchers have been named on a “who’s who” list of the world’s most influential academics. Four experts from the University’s School of Life Sciences, and a further two from the School of Medicine, have been named in Clarivate’s Highly Cited Researchers 2020 list.

  • Dundee Discoveries Past and Present
    16 Nov 2020

    Locals are invited to explore Dundee’s innovation and discovery in medicine and biology in a new series of self-guided walking tours produced by the University of Dundee.   Dundee is celebrated internationally for its pioneering work in medical sciences, in particular the University of Dundee’s ground-breaking research into cancer, diabetes, drug development and surgical techniques, but the city has a great deal of extraordinary stories in medicine and biology still unknown to many. 

  • Professor Victoria Cowling
    06 Nov 2020

    Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development. Softech received funding via Scottish Enterprise’s in-year High Growth Spin-out Programme (HGSP) while RNACapRx and Data Driven Health Solutions received support as part of an additional funding package for innovative early stage businesses whose routes to investment and growth have been impacted by the Covid-19 pandemic.

  • From left: Nicola Darling and Kris Clark
    03 Nov 2020

    Research by Kris Clark, a former postdoc in Philip Cohen lab, led to the discovery eight years ago that the SIK subfamily of protein kinases suppress the production of the anti-inflammatory cytokine IL-10 by phosphorylating and activating CRTC3, co-activator of the transcription factor CREB.  Excitingly, pharmacological inhibition of the SIKs greatly enhanced the production of IL-10, and transformed macrophages from an inflammatory M1 state to an anti-inflammatory M2b state that is thought to be important for the resolution of inflammation and the repair of tissue damage.

October 2020

  • Julia Wcislo Runner-up in Max Perutz Science Writing Award 2020
    28 Oct 2020

    Earlier this month, Julia Wcislo was named runner-up in the Medical Research Council’s Max Perutz Science Writing Award at their virtual award ceremony. Julia, an MRC funded PhD student in Kevin Read’s lab in the Drug Discovery Unit and Wellcome Centre for Anti-Infectives Research, received a runner-up prize of £750 for her article, “The game of hide-and-seek”.

  • 26 Oct 2020

    National UK SPINE initiative created to help us stay healthy in later years Innovative research aims to target the processes behind ageing rather than treating individual diseases Flagship projects include new pipeline to transform and accelerate development of ageing therapeutics Number of people over 75 in the UK will be one in seven by 2040, with challenges for health and care services alongside opportunities to improve quality of life

  • Francisco Bustos and Greg Findlay
    19 Oct 2020

    Latest research from Greg Findlay’s lab in the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) is published today in Developmental Cell. The work discovered a new pathway which is disrupted in people with Intellectual Disability and could provide a new therapeutic strategy for these individuals.

  • Megan Bergkessel and Adam Fletcher
    19 Oct 2020

    Two life sciences researchers have been awarded Future Leaders Fellowships from UK Research and Innovation (UKRI). Dr Megan Bergkessel, Principal Investigator in the Division of Molecular Microbiology, was awarded over £900k to research how some bacteria can survive in inhospitable environments and the potential for new treatments. Dr Adam Fletcher, a postdoctoral researcher in Dr Satpal Virdee's lab in the MRC PPU, will use the award to begin his independent research programme at the MRC-University of Glasgow Centre for Virus Research (CVR) at the University of Glasgow.

Pages